BIOARCTIC AB |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 196.4 SEK | -1.33% |
|
+4.99% | -26.14% |
| 22/04 | Nordic Stocks Closed Up Monday; Getinge Series B Climbed Highest | DJ |
| 20/04 | BioArctic AB and Eisai Co., Ltd. Sign Research Evaluation Agreement Regarding BAN2802 | CI |
Chart calendar BioArctic AB
44e3cc428bb2.S1MGYnjoeNMc-RWC-Dj6AT82Y7M2uq13au6u4vCKM9o.HCRXNhqrCZdXr3H3j3OKORIHKuBg3eIcXL7dgJGzUZQaOVA9LYIpoXagJQ~3ff3cf9e2dc977ecc42d2c50efd402a8
Upcoming events on BioArctic AB
Past events on BioArctic AB
| 09/03/2024 02:55 pm | Alzheimer and Parkinson Diseases International Conference - Structural dynamics of amyloid-? protofi |
| 09/03/2024 02:40 pm | Alzheimer and Parkinson Diseases International Conference - Lecanemab for the treatment of early Alz |
| 09/03/2024 02:10 pm | Alzheimer and Parkinson Diseases International Conference - Binding characteristics of lecanemab, do |
| 08/03/2024 | Alzheimer and Parkinson Diseases International Conference - Presentation : P0111 / #943 |
| 08/03/2024 | Alzheimer and Parkinson Diseases International Conference - Presentation P0110 / #562 |
| 08/03/2024 | Alzheimer and Parkinson Diseases International Conference - Presentation P0213 / #1510 |
| 07/03/2024 08:50 pm | Alzheimer and Parkinson Diseases International Conference - Novel approaches to clinical development |
| 07/03/2024 07:20 pm | Alzheimer and Parkinson Diseases International Conference - Treatment with lecanemab disrupts tau ac |
| 07/03/2024 04:40 pm | Alzheimer and Parkinson Diseases International Conference - Defining meaningful benefits to patients |
| 05/03/2024 | Alzheimer and Parkinson Diseases International Conference |
| 14/02/2024 02:00 pm | Q4 2023 Earnings Call |
| 14/02/2024 12:30 pm | Q4 2023 Earnings Release |
| 06/02/2024 09:38 am | Q4 2023 Sales and Revenue Release |
| 08/11/2023 02:00 pm | Q3 2023 Earnings Call |
| 08/11/2023 12:30 pm | Q3 2023 Earnings Release |
| 07/11/2023 09:46 am | Q3 2023 Sales and Revenue Release |
| 27/10/2023 12:20 am | Clinical Trials on Alzheimer Disease Conference |
| 26/10/2023 02:35 am | Clinical Trials on Alzheimer Disease Conference |
| 24/10/2023 | Clinical Trials on Alzheimer Disease Conference - LP011Impact of a Site Supplemental Funding Program |
| 24/10/2023 | Clinical Trials on Alzheimer Disease Conference - P045ARIA by Clinical Subgroup and Baseline Amyloid |
Past dividends on BioArctic AB
| 10/05/2019 | Annual 1.5 SEK |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 282 294 -4.07% | 65,9 57,6 14.46% | 23,1 121 -80.83% | 230 220 4.71% | 616 559 10.2% | 502 |
|
EBITDA Million SEK | Released Forecast Spread | 122 71,6 70.05% | -74,0 -152 51.22% | -127 -60,2 -110.39% | -2,81 -10,5 73.25% | 271 277 -2.06% | 4,50 |
|
EBIT Million SEK | Released Forecast Spread | 113 72,3 55.54% | -85,0 -151 43.69% | -140 -59,5 -134.88% | -17,4 -78,1 77.68% | 253 264 -4.42% | 2,07 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 113 72,2 56.52% | -86,7 -152 42.92% | -141 -60,3 -132.92% | -11,2 -34,1 67.22% | 276 209 32.35% | 34,5 |
|
Net income Million SEK | Released Forecast Spread | 88,5 56,4 57.03% | -68,5 -142 51.78% | -120 -60,3 -98.66% | -11,2 -64,6 82.7% | 229 183 25.1% | 16,9 |
|
EPS SEK | Released Forecast Spread | 1,00 0,64 56.25% | -0,78 -1,31 40.63% | -1,36 -0,68 -99.12% | -0,13 -0,72 81.84% | 2,59 2,09 24.22% | 0,20 |
| Announcement Date | 06/02/20 | 04/02/21 | 03/02/22 | 03/02/23 | 14/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 2,75 3,00 -8.47% | 209 119 75.49% | 11,0 15,9 -30.67% | 18,2 | 311 | 52,1 | 65,5 | ||
|
EBIT Million SEK | Released Forecast Spread | -101 -94,0 -7.31% | 131 23,0 469.62% | -78,1 -67,8 -15.19% | -81,8 | 195 | -74,9 | -82,0 | ||
|
Net income Million SEK | Released Forecast Spread | -44,3 | 294 | |||||||
|
EPS SEK | Released Forecast Spread | -0,50 | 3,31 | -1,16 -0,98 -18.37% | 1,41 2,00 -29.5% | -0,99 -0,90 -10% | -0,80 | 2,20 | -0,50 | -0,50 |
| Announcement Date | 28/04/22 | 27/04/23 | 12/07/23 | 08/11/23 | 14/02/24 | - | - | - | - |
| 01/05/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 04:00 pm | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 04:00 pm | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 04:30 pm | ALKERMES PLC: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for BioArctic AB
| Today | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 01:35 am | QIAGEN N.V.: Q1 2024 Earnings Release |
| 30/04/2024 01:31 am | MORPHOSYS AG: Q1 2024 Earnings Release |
| 29/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 29/04/2024 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release |
| 28/04/2024 | SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release |
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BIOA B Stock
- Calendar BioArctic AB
